And or Refractory Multiple Myeloma

• CLINICAL_TRIALS trial_result · 2023-12-07
  Clinical Trial Update: A Study in Relapsed and/or Refractory Multiple Myeloma Patients Treated With Ixazomib Plus Lenalidomide and Dexamethasone

  Clinical trial update for ixazomib plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma has completed with results po…

• CLINICAL_TRIALS trial_result · 2022-08-22
  Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Ixazomib in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma Initially Treated With an Injection of Proteasome Inhibitor-Based Therapy [Phase 4]

  Phase 4 trial assessing ixazomib with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma after initial proteasome inhibi…

• CLINICAL_TRIALS trial_result · 2020-09-18
  Clinical Trial Update: A Study of Ixazomib Plus Lenalidomide and Dexamethasone in Adult Japanese Participants With Relapsed and/or Refractory Multiple Myeloma [Phase 2]

  Phase 2 trial evaluating ixazomib plus lenalidomide and dexamethasone in adult Japanese patients with relapsed/refractory multiple myeloma h…

• CLINICAL_TRIALS trial_result · 2020-02-28
  Clinical Trial Update: A Study of MLN9708 in Japanese Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM) [Phase 1]

  Phase 1 clinical trial of MLN9708 in Japanese participants with relapsed/refractory multiple myeloma was terminated; results posted.

• CLINICAL_TRIALS trial_result · 2020-02-20
  Clinical Trial Update: The Safety and Efficacy of Pomalidomide in Combination With Cyclophosphamide and Dexamethasone (PCD) in the Transplant-ineligible Patients With Relapsed and/or Refractory Multiple Myeloma (MM) [Phase 2]

  Phase 2 trial evaluating pomalidomide with cyclophosphamide and dexamethasone (PCD) for transplant-ineligible relapsed/refractory multiple m…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.